Journal ArticleOPEN ACCESS

Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen's effectiveness and increase the risk of death from breast cancer?

Breast Cancer Research (2010) 12(SUPPL. 4)
DOI: 10.1186/bcr2747
6Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Pritchard, K. I. (2010). Do selective serotonin receptor inhibitor antidepressants reduce tamoxifen’s effectiveness and increase the risk of death from breast cancer? Breast Cancer Research, 12(SUPPL. 4). https://doi.org/10.1186/bcr2747

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free